References
Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK (2017) Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol 23:6137–6146
Arguelles-Arias F, Castro-Laria L, Lobaton T et al (2013) Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci 58:2949–2954
Hagen JW, Swoger JM, Grandinetti LM (2015) Cutaneous manifesta tions of Crohn disease. Dermatol Clin 33:417–431
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from the participant included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rizzuto, A., Gallo, G., Trompetto, M. et al. Pyoderma gangrenosum as first manifestation of Crohn’s disease. Tech Coloproctol 23, 79–80 (2019). https://doi.org/10.1007/s10151-018-1916-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-018-1916-9